Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05803746
Status:
RECRUITING
Last Update Posted:
2023-04-07
First Post:
2023-03-27
Brief Title:
PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Study Overview
Official Title:
PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
Status:
RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to construct a noninvasive approach using 68Ga- Mirc415 PETCT to detect the PD-L2 expression of tumor lesion in patients with colorectal cancer lung cancer and other solid tumor to identify patients benefiting from anti-PD-L1 treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None